Rl. Bush et al., Early experience with the bifurcated Excluder endoprosthesis for treatmentof the abdominal aortic aneurysm, J VASC SURG, 34(3), 2001, pp. 497-502
Citations number
11
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Purpose: This report describes our initial experience with the modular, bif
urcated Excluder endoprosthesis and its safety and efficacy in the primary
endovascular repair of infrarenal abdominal aortic aneurysms (AAAs).
Methods: AAAs (mean diameter, 58.2 +/- 14.3 mm) were repaired in 19 patient
s with this device between March 1999 and January 2000. The mean age of pat
ients was 71.8 +/- 8.4 years (range, 57-86 years). This modular device was
inserted through an 18F introducer sheath placed in one femoral artery, and
the contralateral artery was cannulated with a 12F introducer sheath. All
procedures were performed in a standard operating room with angiographic ca
pabilities.
Results: Endograft deployment was successful in all patients. The average s
urgical time was 135 +/- 37 minutes, with a mean blood loss of 229 +/- 138
mL. In eight patients, the use of either aortic or iliac extenders was requ
ired for enhanced sealing or additional length. An external iliac artery di
ssection occurring at the time of endograft insertion was successfully trea
ted with a Wallstent. Type II leaks initially found to be present by means
of intraoperative completion angiography had spontaneously thrombosed by th
e 1-month follow-up computed tomography scan. There was one perioperative d
eath (5.3%). Complications included superficial wound infections (n = 3) an
d a nonfatal myocardial infarction (n = 1). The mean length of hospital sta
y was 2.9 +/- 1.2 days, and only six patients required intensive care. Endo
leaks were seen in four patients (21%) by means of the 30-day computed tomo
graphy scan; three of these endoleaks had spontaneously sealed at the time
of the 6-month follow-up examination (5.5% 6-month endoleak rate). Aneurysm
size did not increase in the patients with leaks.
Conclusion: The Excluder endoprosthesis was an effective means of excluding
an infrarenal AAA from the systemic circulation in this selected group of
patients. The smaller sheath sizes may increase the pool of potential candi
dates. Further study of this device is warranted, and continued assessment
of the long-term durability of the device win be necessary.